BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 11952673)

  • 1. Antineutrophil cytoplasmic antibody in children with nephrotic syndrome treated with levamisole: a cross-sectional cohort study.
    Sinha R; Sarkar S; Banerjee S; Akhtar S; Poddar S; Dasgupta D; Saha R; Sengupta J; Mandal M; Tse Y; Pahari A
    Pediatr Nephrol; 2024 Aug; 39(8):2423-2427. PubMed ID: 38589697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coincidence of Systemic Lupus Erythematosus and ANCA-Associated Vasculitis: A Case Report with Perforation of Nasal Septum and Palate.
    Liu Y; Yu S; Ma S; Yu J; Zuo D; Zhao W; Wang J; Wang J
    J Inflamm Res; 2023; 16():5949-5957. PubMed ID: 38084107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Tangled Autoimmune Trio: Multiple Sclerosis, Systemic Lupus Erythematosus and Antineutrophil Cytoplasmic Antineutrophil Cytoplasmic Antibody Vasculitis.
    Namas R; Qassimi SA; Ghosn M; Memisoglu E; Alduaij A; Herlitz L; Mifsud VA
    Eur J Rheumatol; 2023 Oct; 10(4):176-178. PubMed ID: 37850606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Level and avidity of antineutrophil cytoplasmic antibodies specific to lactoferrin are useful biomarkers in systemic lupus erythematosus.
    Gajic-Veljic M; Lekic B; Nikolic M; Lalosevic J; Stojimirovic B; Bonaci-Nikolic B
    Clin Rheumatol; 2022 Mar; 41(3):709-720. PubMed ID: 34618258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clearance Deficiency and Cell Death Pathways: A Model for the Pathogenesis of SLE.
    Mahajan A; Herrmann M; Muñoz LE
    Front Immunol; 2016; 7():35. PubMed ID: 26904025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapidly progressive lupus nephritis with extremely high levels of antineutrophil cytoplasmic antibodies.
    Koenig KF; Kalbermatter SA; Menter T; Mayr M; Kiss D
    Case Rep Nephrol Urol; 2014 Jan; 4(1):5-11. PubMed ID: 24575116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression in systemic lupus erythematosus: bone marrow analysis differentiates active from inactive disease and reveals apoptosis and granulopoiesis signatures.
    Nakou M; Knowlton N; Frank MB; Bertsias G; Osban J; Sandel CE; Papadaki H; Raptopoulou A; Sidiropoulos P; Kritikos I; Tassiulas I; Centola M; Boumpas DT
    Arthritis Rheum; 2008 Nov; 58(11):3541-9. PubMed ID: 18975309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-neutrophil cytoplasmic antibodies in new-onset systemic lupus erythematosus and lupus nephritis.
    Pan HF; Fang XH; Wu GC; Li WX; Zhao XF; Li XP; Xu JH; Ye DQ
    Inflammation; 2008 Aug; 31(4):260-5. PubMed ID: 18528749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defensins- and cathepsin G-ANCA in systemic lupus erythematosus.
    Tamiya H; Tani K; Miyata J; Sato K; Urata T; Lkhagvaa B; Otsuka S; Shigekiyo S; Sone S
    Rheumatol Int; 2006 Dec; 27(2):147-52. PubMed ID: 16900373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational requesting or rationing testing?
    Lock RJ
    J Clin Pathol; 2004 Feb; 57(2):121-2. PubMed ID: 14747431
    [No Abstract]   [Full Text] [Related]  

  • 12. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.
    Schnabel A; Csernok E; Isenberg DA; Mrowka C; Gross WL
    Arthritis Rheum; 1995 May; 38(5):633-7. PubMed ID: 7748219
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of eight commercial kits for quantitation of antineutrophil cytoplasmic antibodies (ANCA).
    Wang G; Csernok E; de Groot K; Gross WL
    J Immunol Methods; 1997 Oct; 208(2):203-11. PubMed ID: 9433475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features.
    Nishiya K; Chikazawa H; Nishimura S; Hisakawa N; Hashimoto K
    Clin Rheumatol; 1997 Jan; 16(1):70-5. PubMed ID: 9132329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANCA in patients with systemic lupus erythematosus. A cross sectional study in Brazilian patients and review of literature.
    Nisihara R; Vithoft G; Alencar I; Dos Santos TAFG; Skare TL
    Lupus; 2024 May; 33(6):574-586. PubMed ID: 38506239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus.
    Sen D; Isenberg DA
    Lupus; 2003; 12(9):651-8. PubMed ID: 14514126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus.
    Molnár K; Kovács L; Kiss M; Husz S; Dobozy A; Pokorny G
    Clin Exp Dermatol; 2002 Jan; 27(1):59-61. PubMed ID: 11952673
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.